Antibody

Researchers at VUMC and Parse Biosciences, an innovator in single-cell sequencing, today announced a strategic collaboration aimed at generating a single-cell “atlas” that potentially will lead to new antibody therapies against measles, mumps and rubella. Researchers will scan the landscape of plasmablasts, the first antibody-producing, B-type immune cells that respond to MMR infection using Parse's technology, which can sequence more than 10 million cells in a single run. Read More

Scientists from Vanderbilt University, the Universidad de la República in Uruguay, and other research centers have achieved a scientific tour de force — resurrecting a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life… Read More